Heterogeneity of Treatment Response to Citalopram for Alzheimer Disease Patients with Aggression or Agitation: The CitAD Randomized Clinical Trial

OBJECTIVE: Pharmacological treatments for agitation and aggression in Alzheimer disease patients have shown limited efficacy. We assessed the heterogeneity of response to citalopram in order to identify individuals who may be helped or harmed. METHODS: In this double-blinded, parallel-group multicen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Psychiatry
Main Authors: Schneider, Lon S., Frangakis, Constantine, Drye, Lea T, Devanand, D.P., Marano, Christopher M., Mintzer, Jacob, Mulsant, Benoit H., Munro, Cynthia A., Newell, Jeffery A., Pawluczyk, Sonia, Pelton, Gregory, Pollock, Bruce G, Porsteinsson, Anton P., Rabins, Peter V., Rein, Lisa, Rosenberg, Paul B., Shade, David, Weintraub, Daniel, Yesavage, Jerome, Lyketsos, Constantine G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6419726/
https://ncbi.nlm.nih.gov/pubmed/26771737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.ajp.2015.15050648
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados